ArticleJAMA neurology2020

Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment.

Jeffrey M Gelfand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.